CTRI/2014/07/004767
Completed
未知
Prediction of tumor response to neo-adjuvant therapy in adenocarcinomas of the gastroeosphageal junction (AEG) using FDG PET/CT
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Patients taking treatment of cancer
- Sponsor
- ot Applicable
- Enrollment
- 75
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All operated patients of esophageal adenocarcinoma who have undergone pre and post neo\-adjuvant chemotherapy FDG PET/CT.
Exclusion Criteria
- •Previously operated patients
- •Patients who have not undergone either the baseline or the post NACT PET/CT
- •Patients who have received chemotherapy or radiation therapy prior to the initial PET/CT.
- •Patients who are operated without receiving NACT.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Predicting tumor response to neoadjuvant chemotherapy in esophageal cancer patients-correlation between hypoxic imaging and signal transduction pathwaysesophageal cancerJPRN-UMIN000045299Institute of Advanced Clinical Medicine, Kindai University40
Recruiting
Not Applicable
Response prediction of neoadjuvant therapy in advanced pancreatic cancer (Neo-Response-Trial)C25Malignant neoplasm of pancreasDRKS00027840Klinik und Poliklinik für Viszeral-, Thorax- und Gefäßchirurgie, Universitätsklinikum Carl Gustav Carus der TU Dresden310
Not yet recruiting
Not Applicable
Prediction of response to Neoadjuvant chemotherapy(bi-weeklyS1/Docetaxel therapy) in advanced gastric cancerGastric cancerJPRN-UMIN000011521Yokohama City University School of Medicine Department of Gastroenterological Surgery50
Terminated
Not Applicable
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast CancerBreast CancerNCT01007890Precision Therapeutics134
Recruiting
Not Applicable
Clinical study: Early prediction of tumor response using imaging and molecular biomarkers of hormone sensitive breast cancer in neoadjuvant hormonal therapy settingHormonal sensitive breast cancerJPRN-UMIN000013815Saitama International Medical Center30